Correlations between vascular invasion, neural structures invasion and microvessel density with clinicopathological parameters in gastric cancer

Open access


Aim: Our objective in conducting this study was to estimate the presence of lymphatic, blood vessel and neural invasion on Hematoxylin & Eosin (H&E) staining and also, the microvessel density detected by immunohistochemistry (MVD), in gastric adenocarcinoma, as well as their relationship with the clinical, pathological and biological characteristics of the tumors. Materials and Methods: To assess the vascular and neural invasion in our study, we included 367 patients diagnosed with gastric cancer. For the immunohistochemical study of MVD, from all cases with gastric carcinoma, we selected 28 patients, 12 patients with gastric biopsy and 16 patients with total gastric resection, which established the TNM stage. All the gastric biopsies and surgical samples were prepared using the paraffin-embedding method and H&E staining and using anti-CD31 and anti-CD34 antibodies for the assessment of intratumoral MVD. Results: The positive blood vessel invasion was associated in a significant way with advanced stages (p <0.01) and high grade carcinomas (p<0.01), while lymphatic invasion was very significant associated only with advanced stage tumors (p < 0.001). Regarding peri- and intraneural invasion, there was a significant matching with the female gender (p < 0.05), advanced stages of disease (p < 0.001), the diffuse type of gastric carcinoma (p <0.05), and with poorly differentiated tumors (p<0.05). There was a close relationship between CD34 MVD and the diffuse type of gastric carcinomas, according to Lauren’s classification (p<0.05), and poorly differentiated tumors (p<0.05). The CD34 MVD values mean was significant correlated with TNM stage, especially III and IV stages (p<0.01). Conclusions: Blood vessel invasion, neural invasion and CD34 MVD play a significant role in tumors biological behavior and they can be used as important prognostic parameters which describes the aggressiveness of gastric carcinomas.

1. Accetta AC, Manso JE, Mello EL, Paiva RK, Castro Ldos S, Accetta P. Type IV Borrmann gastric adenocarcinoma: analysis of curative resection results. Rev Col Bras Cir. 2011; 38(4): 237-44. DOI: 10.1590/S0100-69912011000400007

2. Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N, Kitano S. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer. 2000; 89(7): 1418-24.



3. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC Cancer Staging Handbook 6th Edition. American Joint Committee on Cancer. 2002; 111-9. DOI: 10.1007/978-1-4757-3656-4

4. Minsky B, Cohen AM. Blood vessel invasion in colorectal cancer-an alternative to TNM staging? Ann Surg Oncol. 1999; 6: 129-130. DOI: 10.1007/s10434-999-0129-x

5. Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH.

Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol. 2002; 9: 562-7.

DOI: 10.1007/BF02573892

6. Batsakis JG. Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol. 1985; 94: 426-7.

7. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature.

Cancer. 2009; 115: 3379-91. DOI: 10.1002/cncr.24396

8. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992, 267(16): 10931-4.

9. Suzuki S, Dobashi Y, Hatakeyama Y, Tajiri R, Fujimura T, Heldin CH, et al. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphor-ylation, and microvessel density in gastric cancer. BMC Cancer. 2010; 10: 659. DOI: 10.1186/1471-2407-10-659

10. de la Taille A, Katz AE, Bagiella E, Buttyan R, Sharir S, Olsson CA, et al. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31. Am J Clin Pathol. 2000; 113(4): 555-62. DOI: 10.1309/02W2-KE50-PKEFG2G4

11. Choi YH, Choi KC, Park YE. Relationship of transforming growth factor beta 1 to angiogenesis in gastric carcinoma. J Korean Med Sci. 1997; 12(5): 427-32.

12. Zhao HC, Qin R, Chen XX, Sheng X, Wu JF, Wang DB, et al. Microvessel density is a prognostic marker of human gastric cancer. World J Gastroenterol. 2006; 12(47): 7598-603.

13. Lauren PA. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma.

An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965; 64:31-49.

14. American Joint Committee on Cancer. Stomach. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer, 2002; 99-106.

15. Sobin LH, Wittekind CH, eds. TNM Classification of Malignant Tumors. 6th ed. New York: John Wiley & Sons; 2002.

16. Scartozzi M, Galizia E, Verdecchia L, Berardi R, Graziano F, Catalano V, et al. Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients. Br J Cancer. 2006; 95(4): 445-9. DOI: 10.1038/sj.bjc.6603286

17. Gabbert HE, Meier S, Gerharz CD, Hommel G. Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients. Int. J. Cancer. 1991; 49 (2): 203-7. DOI: 10.1002/ijc.2910490210

18. del Casar JM, Corte MD, Alvarez A, García I, Bongera M, González LO, et al. Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. J Cancer Res Clin Oncol. 2008; 134(2): 153-61. DOI: 10.1007/s00432-007-0264-3

19. Maehara Y, Kabashima A, Koga T, Tokunaga E, Takeuchi H, Kakeji Y, at al. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma.

Surgery. 2000; 128(3): 408-16. DOI: 10.1067/ msy.2000.107265

20. Wang YD, Wu P, Mao JD, Huang H, Zhang F. Relationship between vascular invasion and microvessel density and micrometastasis, World J Gastroenterol. 2007; 13(46): 6269-73. DOI: 10.3748/wjg.13.6269

21. Tianhang L, Guoen F, Jianwei B, Liye M. The effect of perineural invasion on overall survival in patients with gastric carcinoma. J Gastrointest Surg. 2008; 12(7): 1263-7. DOI: 10.1007/s11605-008-0529-4

22. Selçukbiricik F, Tural D, Büyükünal E, Serdengeçti S.

Perineural Invasion Independent Prognostic Factors in Patients with Gastric Cancer Undergoing Curative Resection.

Asian Pacific J Cancer Prev. 2012; 13(7): 3149-52. DOI: 10.7314/APJCP.2012.13.7.3149

23. Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS. Biologic Predictors of Survival in Node-Negative Gastric Cancer. Ann Surg. 2003; 237(6): 828-37. DOI: 10.1097/00000658-200306000-00011

24. Duraker N, Sişman S, Can G. The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma. Surg Today. 2003; 33(2): 95-100.

DOI: 10.1007/s005950300020

25. Folkman J. What is the evidence that tumors are angio- genesis dependent? J Natl Cancer Inst. 1990; 82(1): 4-6. DOI: 10.1093/jnci/82.1.4

26. Tenderenda M, Rutkowski P, Jesionek-Kupnicka D, Kubiak R. Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index. Pathol Oncol Res. 2001; 7(2): 129-34. DOI: 10.1007/BF03032579

27. Zhou YJ, Xiong YX, Wu XT, Shi D, Fan W, Zhou T, et al. Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer.

World J Gastroenterol. 2004; 10(21): 3225-9.

28. Joo YE, Sohn YH, Joo SY, Lee WS, Min SW, Park CH, et al. The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer.

Korean J Intern Med. 2002; 17(4): 211-9.

29. Yang Q, Ye ZY, Zhang JX, Tao HQ, Li SG, Zhao ZS.

Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis. Anat Rec (Hoboken). 2010; 293(12): 2012-9. DOI: 10.1002/ar.21071

30. Du JR, Jiang Y, Zhang YM, Fu H. Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas. World J Gastroenterol. 2003; 9(7): 1604-6.

Revista Romana de Medicina de Laborator

Romanian Journal of Laboratory Medicine

Journal Information

IMPACT FACTOR 2017: 0.400
5-year IMPACT FACTOR: 0.320

CiteScore 2017: 0.31

SCImago Journal Rank (SJR) 2017: 0.144
Source Normalized Impact per Paper (SNIP) 2017: 0.195


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 119 119 9
PDF Downloads 49 49 7